Source: British Journal of Clinical Pharmacology. Unidade: FCFRP
Subjects: MALÁRIA, PLASMODIUM, CITOCINAS, DOENÇA AGUDA, QUIMIOTERAPIA, PACIENTES
ABNT
ALMEIDA, Anne Cristine et al. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients. British Journal of Clinical Pharmacology, v. 87, n. 4, p. 1859-1868, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14574. Acesso em: 11 nov. 2024.APA
Almeida, A. C., Elias, A. B. R., Marques, M. P., Melo, G. C., Costa, A. G., Figueiredo, E. F. G., et al. (2021). Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients. British Journal of Clinical Pharmacology, 87( 4), 1859-1868. doi:10.1111/bcp.14574NLM
Almeida AC, Elias ABR, Marques MP, Melo GC, Costa AG, Figueiredo EFG, Brasil LW, Rodrigues-Soares F, Monteiro WM, Lacerda MVG de, Lanchote VL, Suarez-Kurtz G. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1859-1868.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/bcp.14574Vancouver
Almeida AC, Elias ABR, Marques MP, Melo GC, Costa AG, Figueiredo EFG, Brasil LW, Rodrigues-Soares F, Monteiro WM, Lacerda MVG de, Lanchote VL, Suarez-Kurtz G. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1859-1868.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/bcp.14574